Epidemiology and Pathophysiology of Post-Infectious Functional GI Disorders

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

March 11, 2020

Study Completion Date

March 11, 2020

Conditions
Campylobacter InfectionsIrritable Bowel Syndrome
Interventions
GENETIC

DNA Analysis of Blood Sample

DNA analysis of the genes possibly involved in IBS.

PROCEDURE

Flexible sigmoidoscopy with colonic biopsies

Endoscopy of the subject's lower colon in which biopsies of the lining of the colon will be taken.

PROCEDURE

Small bowel and colonic gastrointestinal permeability

A validated scintigraphic method to measure gastric, small bowel and colonic transit will be used.

DIAGNOSTIC_TEST

Stool sample analysis

Stool samples will be used to extract supernatants. These supernatants will be studied in using chamber set-up to determine barrier effects on T84 monolayers.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Mayo Clinic

OTHER